Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.
Fukumi YoshikawaHiroshi UchinoTomoko NagashimaShuki UsuiMasahiko MiyagiYasuyo AndoTakahisa HirosePublished in: Diabetology international (2021)
The online version contains supplementary material available at 10.1007/s13340-021-00513-6.